Literature DB >> 16896212

In vitro generation of human high-density-lipoprotein-resistant Trypanosoma brucei brucei.

Sara D Faulkner1, Monika W Oli, Rudo Kieft, Laura Cotlin, Justin Widener, April Shiflett, Michael J Cipriano, Sarah E Pacocha, Shanda R Birkeland, Stephen L Hajduk, Andrew G McArthur.   

Abstract

The host range of African trypanosomes is influenced by innate protective molecules in the blood of primates. A subfraction of human high-density lipoprotein (HDL) containing apolipoprotein A-I, apolipoprotein L-I, and haptoglobin-related protein is toxic to Trypanosoma brucei brucei but not the human sleeping sickness parasite Trypanosoma brucei rhodesiense. It is thought that T. b. rhodesiense evolved from a T. b. brucei-like ancestor and expresses a defense protein that ablates the antitrypanosomal activity of human HDL. To directly investigate this possibility, we developed an in vitro selection to generate human HDL-resistant T. b. brucei. Here we show that conversion of T. b. brucei from human HDL sensitive to resistant correlates with changes in the expression of the variant surface glycoprotein (VSG) and abolished uptake of the cytotoxic human HDLs. Complete transcriptome analysis of the HDL-susceptible and -resistant trypanosomes confirmed that VSG switching had occurred but failed to reveal the expression of other genes specifically associated with human HDL resistance, including the serum resistance-associated gene (SRA) of T. b. rhodesiense. In addition, we found that while the original active expression site was still utilized, expression of three expression site-associated genes (ESAG) was altered in the HDL-resistant trypanosomes. These findings demonstrate that resistance to human HDLs can be acquired by T. b. brucei.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896212      PMCID: PMC1539141          DOI: 10.1128/EC.00116-06

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  73 in total

1.  Distribution of apolipoprotein L-I and trypanosome lytic activity among primate sera.

Authors:  Philippe Poelvoorde; Luc Vanhamme; Jan Van Den Abbeele; William M Switzer; Etienne Pays
Journal:  Mol Biochem Parasitol       Date:  2004-03       Impact factor: 1.759

2.  The generic genome browser: a building block for a model organism system database.

Authors:  Lincoln D Stein; Christopher Mungall; ShengQiang Shu; Michael Caudy; Marco Mangone; Allen Day; Elizabeth Nickerson; Jason E Stajich; Todd W Harris; Adrian Arva; Suzanna Lewis
Journal:  Genome Res       Date:  2002-10       Impact factor: 9.043

3.  Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene.

Authors:  S C Welburn; K Picozzi; E M Fèvre; P G Coleman; M Odiit; M Carrington; I Maudlin
Journal:  Lancet       Date:  2001-12-15       Impact factor: 79.321

4.  The role of transferrin-receptor variation in the host range of Trypanosoma brucei.

Authors:  W Bitter; H Gerrits; R Kieft; P Borst
Journal:  Nature       Date:  1998-01-29       Impact factor: 49.962

5.  Apolipoprotein L-I is the trypanosome lytic factor of human serum.

Authors:  Luc Vanhamme; Françoise Paturiaux-Hanocq; Philippe Poelvoorde; Derek P Nolan; Laurence Lins; Jan Van Den Abbeele; Annette Pays; Patricia Tebabi; Huang Van Xong; Alain Jacquet; Nicole Moguilevsky; Marc Dieu; John P Kane; Patrick De Baetselier; Robert Brasseur; Etienne Pays
Journal:  Nature       Date:  2003-03-06       Impact factor: 49.962

6.  Heterogeneity in the properties of the trypanolytic factor in normal human serum.

Authors:  P Lorenz; R W James; J S Owen; B Betschart
Journal:  Mol Biochem Parasitol       Date:  1994-03       Impact factor: 1.759

Review 7.  Trypanosome lytic factors: novel mediators of human innate immunity.

Authors:  J Raper; M P Portela; E Lugli; U Frevert; S Tomlinson
Journal:  Curr Opin Microbiol       Date:  2001-08       Impact factor: 7.934

8.  The serum resistance-associated gene as a diagnostic tool for the detection of Trypanosoma brucei rhodesiense.

Authors:  Magdalena Radwanska; Mustapha Chamekh; Luc Vanhamme; Filip Claes; Stefan Magez; Eddy Magnus; Patrick de Baetselier; Philippe Büscher; Etienne Pays
Journal:  Am J Trop Med Hyg       Date:  2002-12       Impact factor: 2.345

9.  The resistance to human plasma of Trypanosoma brucei, T. rhodesiense and T. gambiense. I. Analysis of the composition of trypanosome strains.

Authors:  F Hawking
Journal:  Trans R Soc Trop Med Hyg       Date:  1976       Impact factor: 2.184

10.  Only the serum-resistant bloodstream forms of Trypanosoma brucei rhodesiense express the serum resistance associated (SRA) protein.

Authors:  C De Greef; E Chimfwembe; J Kihang'a Wabacha; E Bajyana Songa; R Hamers
Journal:  Ann Soc Belg Med Trop       Date:  1992
View more
  12 in total

Review 1.  Trypanosome resistance to human innate immunity: targeting Achilles' heel.

Authors:  Natalie A Stephens; Rudo Kieft; Annette Macleod; Stephen L Hajduk
Journal:  Trends Parasitol       Date:  2012-10-08

2.  Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor.

Authors:  Rudo Kieft; Paul Capewell; C Michael R Turner; Nicola J Veitch; Annette MacLeod; Stephen Hajduk
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

3.  The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human african trypanosomiasis.

Authors:  Andrew P Jackson; Mandy Sanders; Andrew Berry; Jacqueline McQuillan; Martin A Aslett; Michael A Quail; Bridget Chukualim; Paul Capewell; Annette MacLeod; Sara E Melville; Wendy Gibson; J David Barry; Matthew Berriman; Christiane Hertz-Fowler
Journal:  PLoS Negl Trop Dis       Date:  2010-04-13

4.  Haptoglobin-hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors.

Authors:  Whitney Bullard; Rudo Kieft; Paul Capewell; Nicola J Veitch; Annette Macleod; Stephen L Hajduk
Journal:  Virulence       Date:  2012-01-01       Impact factor: 5.882

5.  Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1.

Authors:  Paul Capewell; Nicola J Veitch; C Michael R Turner; Jayne Raper; Matthew Berriman; Stephen L Hajduk; Annette MacLeod
Journal:  PLoS Negl Trop Dis       Date:  2011-09-06

6.  Role of expression site switching in the development of resistance to human Trypanosome Lytic Factor-1 in Trypanosoma brucei brucei.

Authors:  Rudo Kieft; Natalie A Stephens; Paul Capewell; Annette MacLeod; Stephen L Hajduk
Journal:  Mol Biochem Parasitol       Date:  2011-12-29       Impact factor: 1.759

Review 7.  Trypanosoma evansi and surra: a review and perspectives on transmission, epidemiology and control, impact, and zoonotic aspects.

Authors:  Marc Desquesnes; Alan Dargantes; De-Hua Lai; Zhao-Rong Lun; Philippe Holzmuller; Sathaporn Jittapalapong
Journal:  Biomed Res Int       Date:  2013-09-18       Impact factor: 3.411

8.  Digital gene expression analysis of two life cycle stages of the human-infective parasite, Trypanosoma brucei gambiense reveals differentially expressed clusters of co-regulated genes.

Authors:  Nicola J Veitch; Paul C D Johnson; Urmi Trivedi; Sandra Terry; David Wildridge; Annette MacLeod
Journal:  BMC Genomics       Date:  2010-02-22       Impact factor: 3.969

9.  A single amino acid substitution in the group 1 Trypanosoma brucei gambiense haptoglobin-hemoglobin receptor abolishes TLF-1 binding.

Authors:  E DeJesus; R Kieft; B Albright; N A Stephens; S L Hajduk
Journal:  PLoS Pathog       Date:  2013-04-18       Impact factor: 6.823

10.  Trypanosoma brucei gambiense adaptation to different mammalian sera is associated with VSG expression site plasticity.

Authors:  Carlos Cordon-Obras; Jorge Cano; Dolores González-Pacanowska; Agustin Benito; Miguel Navarro; Jean-Mathieu Bart
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.